Ventzislav Kirilov Stefanov
Direktor/Vorstandsmitglied bei MuOx Ltd.
Aktive Positionen von Ventzislav Kirilov Stefanov
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
MuOx Ltd.
 MuOx Ltd. BiotechnologyHealth Technology Part of Summit Therapeutics, Inc., MuOx Ltd. is a British company that develops utrophin modulators and biological screening equipment. The company is based in Abingdon, UK. The company was founded in 2012 by Stephen Davies John Davies. MuOx was acquired by Summit Therapeutics Ltd. on November 25, 2013 for $5.27 million. | Direktor/Vorstandsmitglied | 27.05.2020 | - |
Karriereverlauf von Ventzislav Kirilov Stefanov
Ehemalige bekannte Positionen von Ventzislav Kirilov Stefanov
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SUMMIT THERAPEUTICS INC. | Direktor/Vorstandsmitglied | - | 11.11.2020 |
Discuva Ltd.
 Discuva Ltd. Pharmaceuticals: MajorHealth Technology Discuva Ltd. develops antibiotics and drug-resistant pathogens. It is a drug discovery company focused on the creation of microbial against new emerging and drug-resistant bacterial pathogens. The company is headquartered in Cambridge, the United Kingdom. | Präsident | 01.04.2020 | 11.11.2020 |
Summit Therapeutics Ltd.
 Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | Direktor/Vorstandsmitglied | 24.12.2019 | - |
| Corporate Officer/Principal | 01.04.2020 | - |
Ausbildung von Ventzislav Kirilov Stefanov
| Medical University Sofia | Doctorate Degree |
Statistik
International
| Vereinigtes Königreich | 4 |
| Bulgarien | 2 |
| Vereinigte Staaten | 2 |
Operativ
| Director/Board Member | 3 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SUMMIT THERAPEUTICS INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
Discuva Ltd.
Discuva Ltd. Pharmaceuticals: MajorHealth Technology Discuva Ltd. develops antibiotics and drug-resistant pathogens. It is a drug discovery company focused on the creation of microbial against new emerging and drug-resistant bacterial pathogens. The company is headquartered in Cambridge, the United Kingdom. | Health Technology |
MuOx Ltd.
MuOx Ltd. BiotechnologyHealth Technology Part of Summit Therapeutics, Inc., MuOx Ltd. is a British company that develops utrophin modulators and biological screening equipment. The company is based in Abingdon, UK. The company was founded in 2012 by Stephen Davies John Davies. MuOx was acquired by Summit Therapeutics Ltd. on November 25, 2013 for $5.27 million. | Health Technology |
